# Brady Corp: Form 10-Q for the period ended Jan 31, 2014

- Company: [Brady Corp](/companies/brc.md) (CIK 746598)
- Form: 10-Q
- Filed: 2014-03-05
- Accepted by EDGAR: Mar 5, 2014, 21:15 ET
- Period: 2014-01-31
- Accession: 0000746598-14-000040
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/746598/000074659814000040/brc-2014131x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/746598/000074659814000040/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-01-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-11-01 to 2014-01-31 | $291.2m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 6 months, 2013-08-01 to 2014-01-31 | $598.7m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2013-11-01 to 2014-01-31 | $148.7m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months, 2013-08-01 to 2014-01-31 | $298.3m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2013-11-01 to 2014-01-31 | $142.5m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2013-08-01 to 2014-01-31 | $300.4m | us-gaap:GrossProfit |
| Research and development | 3 months, 2013-11-01 to 2014-01-31 | $8.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2013-08-01 to 2014-01-31 | $17.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2013-11-01 to 2014-01-31 | $111.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2013-08-01 to 2014-01-31 | $224.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2013-11-01 to 2014-01-31 | $18.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2013-08-01 to 2014-01-31 | $48.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2013-11-01 to 2014-01-31 | −$3.7m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2013-08-01 to 2014-01-31 | −$7.4m | us-gaap:InterestExpense |
| Income tax | 3 months, 2013-11-01 to 2014-01-31 | $4.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2013-08-01 to 2014-01-31 | $13.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-11-01 to 2014-01-31 | $16.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2013-08-01 to 2014-01-31 | $40.4m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months, 2013-11-01 to 2014-01-31 | 52,494,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2013-08-01 to 2014-01-31 | 52,457,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2013-08-01 to 2014-01-31 | $41.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2013-08-01 to 2014-01-31 | −$17.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2013-08-01 to 2014-01-31 | −$20.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months, 2013-08-01 to 2014-01-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-01-31 | $79.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-01-31 | $519.9m | us-gaap:AssetsCurrent |
| Total assets | at 2014-01-31 | $1.44bn | us-gaap:Assets |
| Current liabilities | at 2014-01-31 | $289.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-01-31 | $574.6m | us-gaap:Liabilities |
| Long-term debt | at 2014-01-31 | $203.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2014-01-31 | $61.3m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2014-01-31 | $863.4m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/746598/000074659814000040/brc-2014131x10q.htm

Filed Mar 5, 2014.
Source: SEC EDGAR, the filing index for accession 0000746598-14-000040. Last ingested by Listed: Nov 9, 2026, 17:29 ET. No prices; not investment advice.
